PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
01-Dec-2022 BIOPHYTIS ORGANISES A WEBCAST WITH KEY OPINION LEADERS (KOL) ON THE PHASE 2-3 COVA STUDY RESULTS OF SARCONEOS (BIO101) IN THE TREATMENT OF PNEUMONIA IN COVID-19 PATIENTS AT RISK OF RESPIRAT Biophytis
01-Dec-2022 Portfolio company Lysatpharma and joint venture Novaxomx start with research and product development in biosurgical treatment therapies Xlife Sciences AG
30-Nov-2022 PAION AG announces change in Management Board PAION AG
30-Nov-2022 PAION AG: CEO Dr. James Phillips leaves the Company as of 30 November 2022, appointment of Supervisory Board member Gregor Siebert as member and new CEO until 30 November 2023 PAION AG
29-Nov-2022 Vetter-Hackathon 2022: Innovation Booster Through Employee Participation B3C newswire
29-Nov-2022 SOTIO Exercises Option for Novel Antibody-Drug Conjugate Program under Agreement with LegoChem Biosciences B3C newswire
29-Nov-2022 CHEPLAPHARM remains on growth track Cheplapharm AG
29-Nov-2022 Rewind Therapeutics Appoints Dr. Stephen Burbidge to its Management Team Rewind Therapeutics
29-Nov-2022 Bioventure, Minapharm Pharmaceuticals and MiGenTra Sign an Exclusive Agreement for the Commercialization of Multiple Biosimilar Candidates of Alvotech in the Middle East and Africa B3C newswire
29-Nov-2022 APONTIS PHARMA: Number of announced market launches increases to ten Single Pills – Portfolio grows by two in-licensing deals APONTIS PHARMA AG
29-Nov-2022 Evolva: Update on activities to boost Resveratrol Evolva Holding SA
28-Nov-2022 MorphoSys AG: Financial Calendar 2023 MorphoSys AG
28-Nov-2022 Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014 and Art. 2 (2) and (3) of the Delegated Regulation (EU) 2016/1052 Drägerwerk AG & Co. KGaA
28-Nov-2022 Vivoryon Therapeutics N.V.: Vivoryon Therapeutics to Present a Clinical Update on its Novel Oral Small Molecule Varoglutamstat at Clinical Trials on Alzheimer's Disease Conference (CTAD) Vivoryon Therapeutics N.V.
28-Nov-2022 Cannovum AG shares move Dec. 1st 2022 to primary market of Düsseldorf Stock Exchange Cannovum AG
28-Nov-2022 alytas therapeutics collaborates with spin-off from the German Diabetes Center Xlife Sciences AG
26-Nov-2022 Vitruvia Medical AG: Issue of 6.00% Convertibel Bond 2022-2025 Vitruvia Medical AG
25-Nov-2022 Antibacterial silver coating technology: acceleration of human clinical trial through successfully implemented clinical trial protocol changes aap Implantate AG
25-Nov-2022 Eckert & Ziegler Receives Green Light for Phase III Study with PENTIXAFOR Eckert & Ziegler Strahlen- und Medizintechnik AG
25-Nov-2022 Cannovum AG expands management board Cannovum AG